Avita Medical share price climbs on new collaboration

The Avita Medical Ltd (ASX: AVH) share price has rocketed higher in early trade after a new collaboration with the University of Colorado.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Ltd (ASX: AVH) share price has shot 3.93% higher in early trade after announcing a new collaboration with the University of Colorado.

Why is the Avita Medical share price climbing higher?

This morning, Avita announced that it will collaborate with scientists at the Gates Center for Regenerative Medicine at the University of Colorado.

The preclinical research collaboration will work to establish proof of concept and explore further development of a spray-on treatment. The treatment is targeted at genetically modified cells for patients with epidermolysis bullosa (EB).

EB is a group of rare and incurable skin disorders caused by genetic mutation, which can result in skin fragility and blistering.

The Aussie medical company also hopes to find applicability for other genetic skin disorders.

The partnership will pair Avita Medical's patented and proprietary Spray-On Skin Cells expertise with the Gates Center's own technology. Avita will retain the option to exclusively license technologies emerging from the partnership.

Director of the Gates Center for Regenerative Medicine, Dr. Dennis Roop, was excited by the partnership.

Dr. Roop said the Spray-On Skin Cells technology combined with the Center's genetically corrected cells "has the potential to be game changing in the treatment of this disease".

At the time of writing, the Avita share price is up nearly 4% to $0.58 per share.

How has Avita performed in 2019?

It's been a busy 2019 for the Aussie medical group, with the Avita Medical share price rocketing higher across the year.

Avita recently joined the ASX 200 after surging an astonishing 625% higher in 2019. The company currently boasts a market cap of $1.2 billion following its strong share market performance this year.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Guess which ASX 200 stock just jumped 9% on big news

Let's find out what is getting investors excited today.

Read more »